- Report
- September 2025
- 193 Pages
Global
From €5208EUR$5,850USD£4,531GBP
- Report
- September 2025
- 179 Pages
Global
From €5208EUR$5,850USD£4,531GBP
- Report
- September 2025
- 193 Pages
Global
From €5208EUR$5,850USD£4,531GBP
- Report
- September 2025
- 376 Pages
Global
From €5208EUR$5,850USD£4,531GBP
- Report
- September 2025
- 238 Pages
Global
From €5208EUR$5,850USD£4,531GBP
- Report
- September 2025
- 130 Pages
Global
From €5208EUR$5,850USD£4,531GBP
- Report
- September 2025
- 381 Pages
Global
From €5208EUR$5,850USD£4,531GBP
- Report
- September 2025
- 196 Pages
Global
From €5208EUR$5,850USD£4,531GBP
- Report
- September 2025
- 284 Pages
Global
From €5208EUR$5,850USD£4,531GBP
From €4362EUR$4,900USD£3,795GBP
- Report
- September 2025
- 471 Pages
Global
From €5208EUR$5,850USD£4,531GBP
- Report
- September 2025
- 384 Pages
Global
From €5208EUR$5,850USD£4,531GBP
- Report
- September 2025
- 285 Pages
Global
From €5208EUR$5,850USD£4,531GBP
- Report
- September 2025
- 461 Pages
Global
From €5208EUR$5,850USD£4,531GBP
- Report
- September 2025
- 193 Pages
Global
From €5208EUR$5,850USD£4,531GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1113EUR$1,250USD£968GBP
- Clinical Trials
- July 2025
- 80 Pages
Global
From €1780EUR$2,000USD£1,549GBP
- Clinical Trials
- July 2025
- 80 Pages
Global
From €1780EUR$2,000USD£1,549GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1335EUR$1,500USD£1,162GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1780EUR$2,000USD£1,549GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more